in the sequencing database of three paired patients. 1000g, 1000 Genomes database; indels, small insertions and deletions; CDS, coding sequence; UTR, untranslated regions; ncRNA, non-coding RNA.
. Analysis of the cell cycle after transfection of ROBO1 or 2 wild type or mutant. K562 (A and C) and HEL (B and D) leukemia cells were, respectively, transfected with ROBO1 or 2 wild type or mutant, and the cell cycle was determined by flow cytometry after 48 hours. There were no differences observed between ROBO1 or 2 over-expressed cells and control cells, even during co-culture with SLIT2. Error bars throughout represent the s.e.m. The determination for cell cycle was replicated three times.
Supplementary Figure 10. Expression of the mutated protein was verified
by western blot after transfection. K562 and HEL cells were transfected with vector expressing wild-type or mutant ROBO1, or wild-type or mutant ROBO2.
Anti-HA tag antibody was used to assess the expression of ROBO1 (A) and ROBO2 (B). In addition, the background expression of ROBO2 (C) and ROBO1 (D) and the GAPDH (E and F) as internal reference was also determined by protein blotting analysis. The western blot experiments were replicated three times. Statistical significance was determined by one way ANOVA HSD test. Table 1 Clinical characteristics of three paired MDS cases before and after disease progression P1 toP2 had both bone marrow (BM) samples collected at the primary diagnosis and matched oral mucosal epithelial samples, which were defined as the whole-exome sequencing set. IPSS-R, revised international prognostic scoring system. RN, refractory neutropenias; RA, refractory anemia; RCMD, refractory cytopenia with multilineage dysplasia; RAEB-2, refractory anemia with excess blasts-2. P1/2/3, Patient 1/2/3. 
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